Ingredient intelligence report
Ingredient hub · not a branded product review
Verdict
Safety, interactions, or risk profiles deserve extra scrutiny; involve a clinician before experimenting.
Last updated: 28 mars 2026
Overall
Trust score summarizes evidence, safety, and hype gap in our fixed rubric - not a personal recommendation.
Best for
Six editorial checks applied to every published hub. Status reflects our fixed scoring bands, not a product lab test.
Human-outcome data aligns relatively well with how this compound is marketed for common uses.
Dosage discussion is documented on this hub; compare any bottle to studied ranges yourself.
Popular claims run well ahead of what trials support - treat storefront copy skeptically.
This page is an ingredient hub (not a SKU review). Transparency is judged at the evidence-and-claim level, not for a single brand label.
Multiple human studies or quality reviews support core, bounded uses.
Notable interaction, population, or tolerability considerations deserve clinician review.
Formula
This hub treats Metformin as a single compound for analysis. Evidence strength reflects human trial and review signal - not brand formulation claims or proprietary blends unless separately documented.
Metformin
Listed dose (hub)
See dosage notes (varies by product)
Published human trials support several bounded use cases; extrapolation beyond those endpoints is weak.
Why it matters
Retail products vary by salt form, dose, and purity. The hub anchors what the compound can claim in evidence - not every bottle on the shelf.
Credibility
Editorial read of marketing narratives versus trial support and safety context. Not a regulatory finding.
Typical storefront and social narratives versus what human data actually test.
Elevated caution: prioritize safety and clinician input before benefit shopping.
Economics
Ingredient hubs are not pegged to a single SKU or live price feed. The read below ties value posture to evidence and hype - not checkout data.
Strained value context
Value is secondary to risk
When safety and interaction concerns dominate, price comparisons are misleading without clinician oversight.
Higher overall score with equal or lower hype gap in our model - navigation hints, not medical advice or guaranteed substitutes.
Some links elsewhere on the site may earn a commission. Rankings and scores are not influenced by affiliate relationships.
Stronger composite score with contained hype versus Metformin in this dataset.
Stronger composite score with contained hype versus Metformin in this dataset.
Stronger composite score with contained hype versus Metformin in this dataset.
Short answers for search intent. The analysis sections above carry the full nuance.
Literature
Strong for glycemic control; mixed animal longevity signals; human healthy-aging trials ongoing - not settled.
Safety
Lactic acidosis risk contexts (renal failure, acute illness protocols), B12 deficiency with chronic use, GI intolerance.
This entry is informational: metformin is not a typical OTC supplement decision.
Product-level dosing varies. This section is general context, not a prescription.
Shorter pages tuned to how people ask - each links back here for the full file.
A few hand-picked entry points around Metformin: categories, answers to narrow questions, and comparisons.
Grouped near Metformin in the model - not interchangeable.
Soluble fiber with strong evidence for constipation and as a lipid adjunct in some guideline discussions when taken with water.
EPA/DHA support cardiovascular risk reduction contexts in some guidelines; supplements vary widely in quality and dose.
Fibers and oligosaccharides that selectively feed commensal microbes; strongest human stories sit in IBS-style and regularity contexts.
Swaps discussed alongside Metformin - judge each on its own evidence.
No sponsored reviews
Editorial model. No paid verdicts.
Evidence-based analysis
Human trial signal, not storefront copy.
Continuously updated
Hubs revised as synthesis changes.
Scores compress ingredient evidence, dosage discussion, claim stress-testing, and hype gap. Outbound retailer links do not change the model output.
· ·